Abstract
Red blood cells (RBCs) are an essential therapeutic resource; however, insufficient supply and risks of blood-borne infections drive the need for alternative sources. The Bristol Erythroid Lineage – Adult (BEL-A) erythroid progenitor cell line provides a new source for the indefinite production of cultured RBCs, but efficient and scalable bioprocessing strategies are yet to be established. Fluidised bed bioreactors (FBBs), with their low-shear environments and high mass transfer capabilities, can support high-density cultures, particularly at large scales, offering a promising manufacturing platform for BEL-A expansion. However, their optimal operating conditions and effects on BEL-A cell have yet to be defined. Using a design of experiments statistical approach, we systematically investigated how dynamic culture conditions impact BEL-A proliferation within FBBs. A lower media perfusion velocity, reduced initial cell seeding number, and a higher cell density (cells/ml) enhanced cellular proliferation. We demonstrate that FBB culture achieved productivity comparable to static culture whilst offering scalability and reduced manual handling. Importantly, no spontaneous differentiation of BEL-A cells was observed, confirming the system’s suitability for maintaining progenitor cell characteristics. This study is the first to demonstrate the feasibility of FBBs for mammalian single-cell suspension culture, using BEL-A as a model system. Furthermore, our work represents a critical step towards the clinical-scale manufacture of BEL-A cells and unlocking their therapeutic potential as a source of cultured RBCs.
| Original language | English |
|---|---|
| Article number | 109936 |
| Journal | Biochemical Engineering Journal |
| Volume | 225 |
| Early online date | 17 Sept 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 17 Sept 2025 |
Data Availability Statement
DOI for data included in manuscriptAcknowledgements
The authors would like to thank Dr. Stephanie Pellegrin and Professor Ash Toye for guidance and providing us with EPO, BRIC71 and BRIC256.Funding
The authors would like to thank the EPSRC for part-funding D. Phillips’ PhD studentship and ChemoMetec A/S who supplied a NucleoCounter® NC-200™ demonstration unit. This work was supported by the EPSRC [grant numbers EP/N509589/1 & EP/R513155/1].
| Funders | Funder number |
|---|---|
| Engineering and Physical Sciences Research Council | EP/N509589/1 , EP/R513155/1 |
